Virulence Characteristics of -Positive Multidrug-Resistant Clinical Coagulase-Negative Staphylococci
Overview
Authors
Affiliations
Coagulase-negative staphylococci (CoNS) are an important group of opportunistic pathogenic microorganisms that cause infections in hospital settings and are generally resistant to many antimicrobial agents. We report on phenotypic and genotypic virulence characteristics of a select group of clinical, -positive (encoding penicillin-binding protein 2a) CoNS isolates. All CoNS were resistant to two or more antimicrobials with strain 214EP, showing resistance to fifteen of the sixteen antimicrobial agents tested. Aminoglycoside-resistance genes were the ones most commonly detected. The presence of megaplasmids containing both horizontal gene transfer and antimicrobial resistance genetic determinants indicates that CoNS may disseminate antibiotic resistance to other bacteria. species produced six virulence enzymes, including a DNase, gelatinase, lipase, phosphatase, and protease that are suspected to degrade tissues into nutrients for bacterial growth and contribute to the pathogenicity of CoNS. The PCR assay for the detection of biofilm-associated genes found the (encoding laminin-binding protein) gene in all isolates. Measurement of their biofilm-forming ability and Spearman's rank correlation coefficient analyses revealed that the results of crystal violet (CV) and extracellular polymeric substances (EPS) assays were significantly correlated (ρ = 0.9153, P = 3.612e-12). The presence of virulence factors, biofilm-formation capability, extracellular enzymes, multidrug resistance, and gene transfer markers in -positive CoNS clinical strains used in this study makes them powerful opportunistic pathogens. The study also warrants a careful evaluation of nosocomial infections caused by CoNS and may be useful in studying the mechanism of virulence and factors associated with their pathogenicity in vivo and developing effective strategies for mitigation.
The prevalence of multidrug resistance in Staphylococcus hominis isolated from clinical materials.
Szemraj M, Glajzner P, Olszowiec K, Sienkiewicz M Sci Rep. 2025; 15(1):414.
PMID: 39747570 PMC: 11696355. DOI: 10.1038/s41598-024-84500-2.
Liu J, Liu R, Deng R, Zheng S, Shen Z BMC Microbiol. 2023; 23(1):276.
PMID: 37773054 PMC: 10540430. DOI: 10.1186/s12866-023-02997-5.
Nasal Carriage of Methicillin-Resistant Group by Residents of an Urban Informal Settlement in Kenya.
Ayodo C, Mugoh R, Ita T, Ouma C, Jepleting M, Oduor B East Afr Health Res J. 2023; 7(1):76-80.
PMID: 37529492 PMC: 10388619. DOI: 10.24248/eahrj.v7i1.711.
Bertelloni F, Cagnoli G, Bresciani F, Scotti B, Lazzerini L, Marcucci M Antibiotics (Basel). 2023; 12(4).
PMID: 37106998 PMC: 10135123. DOI: 10.3390/antibiotics12040636.
Mao C, Wang Y, Yang Y, Li L, Yuan K, Cao H Microbiol Spectr. 2022; 10(6):e0240922.
PMID: 36453944 PMC: 9769716. DOI: 10.1128/spectrum.02409-22.